|
KNSA Kiniksa Pharmaceuticals Internatinl, PLC 1730430 |
| Balance Sheet |
|
Current Assets
|
$594,172,000.00 |
|
Assets
|
$825,280,000.00 |
|
Current Liabilities
|
$156,611,000.00 |
|
Liabilities
|
$219,593,000.00 |
|
Equity
|
$605,687,000.00 |
|
Shares Out
|
46303000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$50,199,000.00 |
|
Investing Cash Flow
|
$-31,916,000.00 |
| Market Analysis |
Market Cap
|
$3,620,894,600.00 |
|
Price
|
$71.69 |
|
PB
|
0.91 |
|
EPS
|
0.30 |
|
PE
|
65.29 |
|
PS
|
3.49 |
|
FCF
|
$50,038,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:19 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:14 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-24 |
0.17 |
|
| Apr |
May |
Jun |
|
|
2026-04-28 |
0.27 |
|
|
|
| Jul |
Aug |
Sep |
|
|
2025-07-29 |
0.23 |
|
|
|
| Oct |
Nov |
Dec |
|
|
2025-10-28 |
0.23 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view KNSA documents filed with the SEC.
KNSA Filings
Clear
